Dr. Joel Ross has dedicated nearly 40 years to medicine as a physician, clinical researcher, teacher, lecturer, and author. His professional life reflects a consistent commitment to patient care, medical education, and clinical research, with a strong focus on older adults. His achievements include being named Teacher of the Year, becoming the first geriatrician in New Jersey, and establishing the state's first geriatric fellowship program. He has also been recognized as a Best Doctor in New Jersey and has contributed to the development of FDA-approved oral and transdermal medications for Alzheimer’s disease. He is the founder and CEO of J&D Pharmaceuticals LLC in Monmouth, New Jersey.

His clinical expertise centers on geriatric medicine, including the diagnosis and treatment of conditions associated with aging. Dr. Ross has focused on caring for patients with cognitive disorders while also managing a wide range of medical conditions that affect older adults. His work emphasizes careful evaluation, evidence-based decision-making, and long-term continuity of care.

On a personal level, he has been happily married for nearly 47 years and maintains an active lifestyle. He is ranked number one in the country at the highest level of expertise in men’s doubles pickleball, ages 70-74, and is ranked in the top 5 nationally in men’s singles. His accomplishments include many gold, silver, and bronze medals earned in both singles and doubles competition.

Dr. Joel Ross received his undergraduate education at Hofstra University in Hempstead, New York, where he earned a BA in Biology. He later obtained his Medical Degree from Downstate Medical Center in Brooklyn and became chief resident at Nassau County Medical Center. He completed a Fellowship in Geriatric Medicine at Mt. Sinai Medical Center in New York under the mentorship of Dr. Robert N. Butler, the first Director of the National Institute on Aging.

Following his formal training, he was selected as the first Medical Director of the Anna Alexander Greenwall Geriatric Program at Monmouth Medical Center, an endowed position. He also served as Director of the Geriatric Fellowship Program at Monmouth Medical Center, which became the first geriatric fellowship program in New Jersey and trained physicians who later practiced throughout the state and the United States.

He later served for seven years as Director of the Geriatrics Section in the Department of Internal Medicine at Jersey Shore Medical Center in Neptune. In 2000, he opened the Memory Enhancement Center of America in New York and New Jersey, where multidisciplinary teams provided care for patients with cognitive disorders and conducted clinical research focused on Alzheimer’s disease.

Dr. Joel Ross has also played an essential role in pharmaceutical development and clinical research leadership. He co-founded RN NanoPharmaceuticals, LLC, in Monmouth Beach, and in 2023, founded J&D Pharmaceuticals, continuing his long-standing focus on translating scientific research into potential treatments for severe medical conditions.

Through this work, he and his collaborators completed an animal study on traumatic brain injury at the University of Oklahoma. In that study, proprietary compound JD-005 reduced acetylated tau levels and significantly improved neurological outcomes in rats following head trauma.

He and his colleagues at the University of Florida in Gainesville are currently conducting clinical research examining acetylated tau as a biomarker in traumatic brain injury patients. J&D Pharmaceuticals has received three Orphan Drug Designations from the U.S. Food and Drug Administration for compounds JD-004 and JD-005, including for Autosomal Dominant Polycystic Kidney Disease, Progeria and related laminopathies, and hepatocellular carcinoma. In addition to his research leadership, he has lectured widely, authored peer-reviewed publications, holds several patents, and volunteers at Parker Health Center in Red Bank, where he provides free medical care, testing, and medications to underserved populations.

Dr. Joel Ross has dedicated nearly 40 years to medicine as a physician, clinical researcher, teacher, lecturer, and author. His professional life reflects a consistent commitment to patient care, medical education, and clinical research, with a stron... Show more

Java developer for 25 years, Frontend (React and Angular) developer for 5 years. Fan of Test Driven Development. Cycling fan.

Java developer for 25 years, Frontend (React and Angular) developer for 5 years. Fan of Test Driven Development. Cycling fan. Show more

Patrick Junghanns is a product management professional with a strong background in molecular diagnostics and healthcare innovation. Currently working as a Product Manager for Connected Consumables, he focuses on developing connected solutions to improve patient safety and optimize clinical workflows. Prior to this, he gained extensive experience across oncology and IV workflow management in international roles, combining technical expertise with marketing and sales capabilities. With an academic foundation in molecular and cellular biology, he brings a scientific mindset to business challenges and enjoys translating complex information into practical solutions

Patrick Junghanns is a product management professional with a strong background in molecular diagnostics and healthcare innovation. Currently working as a Product Manager for Connected Consumables, he focuses on developing connected solutions to impr... Show more

Brad Schlicht is a Distinguished Engineer at Medtronic, where he focuses on modernizing cloud architecture and building out next-generation platform capabilities to accelerate product development.

His background spans building distributed on-premise infrastructure solutions, platform engineering, DevSecOps, and cloud architecture across several premier Minnesota-based companies.

Currently, Brad is focused on embedding Generative AI and Agentic AI workflows throughout the software development lifecycle (SDLC), building intelligent developer experience (DevEx) platforms that eliminate friction and increase engineering velocity at scale.

Brad Schlicht is a Distinguished Engineer at Medtronic, where he focuses on modernizing cloud architecture and building out next-generation platform capabilities to accelerate product development. His background spans building distributed on-prem... Show more

David is a technologist practicing at the intersection of computing and culture. He has worked on problems related to digital identity, reproducible data science, and software preservation, exhibited interdisciplinary art across Europe and the United States, and taught at Stevens Institute of Technology and the Illinois Institute of Art. He currently opines on technology in the public interest at Beyond the Frame and applies those ideas as the CTO of Yorba.

David is a technologist practicing at the intersection of computing and culture. He has worked on problems related to digital identity, reproducible data science, and software preservation, exhibited interdisciplinary art across Europe and the United... Show more

Paola Haka is Deputy Director for Aerospace & Defense Strategic Projects at GlobalFoundries in Dresden. She leads strategic initiatives at the intersection of semiconductor manufacturing, business transformation, and European industry collaboration.
With a strong track record in driving large-scale programs, she works closely with industry and public stakeholders to advance resilient and competitive semiconductor ecosystems in Europe. Her focus is on translating complex technological challenges into sustainable, scalable solutions that strengthen Europe’s position in the global semiconductor landscape.

Paola Haka is Deputy Director for Aerospace & Defense Strategic Projects at GlobalFoundries in Dresden. She leads strategic initiatives at the intersection of semiconductor manufacturing, business transformation, and European industry collaboration. ... Show more

I currently work as a Software Consultant at TNG (since 2021), where I've contributed to projects involving search algorithm development and data platform engineering—particularly systems analyzing user interactions with web products. Outside of client work, I engage in projects focused on refining language models. Before joining TNG, I developed algorithms for medical applications. My background includes a PhD in theoretical physics with specialization in particle physics.

I currently work as a Software Consultant at TNG (since 2021), where I've contributed to projects involving search algorithm development and data platform engineering—particularly systems analyzing user interactions with web products. Outside of clie... Show more

C. A. Fillekes is an IBM Red Hat partner engineer, actively porting and testing Kubernetes and OpenShift add-ons and features on the s390x architecture to run on the LinuxONE and System Z platforms.

C. A. Fillekes is an IBM Red Hat partner engineer, actively porting and testing Kubernetes and OpenShift add-ons and features on the s390x architecture to run on the LinuxONE and System Z platforms. Show more

Katherine Draheim is a Marketing & Campaign Manager with five years of experience in national and international marketing automation campaigns. She specialises in planning, executing and optimising integrated, omnichannel marketing strategies across digital channels, from email automation and social media to webinars and events. Her work in the life sciences and biotech industry has been recognised with the Best Campaign Award 2024 by Scileads.

Katherine Draheim is a Marketing & Campaign Manager with five years of experience in national and international marketing automation campaigns. She specialises in planning, executing and optimising integrated, omnichannel marketing strategies across ... Show more

I am a data enthusiast transitioning from a career in oceanography and ecology to data science. Since 2022, I have been exploring Shiny and learning how to create user-friendly applications for survey monitoring. While I’m not an expert developer yet, I am passionate about simplifying complex processes for non-technical users and sharing what I learn along the way. My background in environmental sciences and statistics helps me bring a unique perspective to problem-solving and data visualization.

I am a data enthusiast transitioning from a career in oceanography and ecology to data science. Since 2022, I have been exploring Shiny and learning how to create user-friendly applications for survey monitoring. While I’m not an expert developer yet... Show more

I'm Josh Nel and I'm a Johannesburg-based freelance data analyst, storyteller, and community strategist working at the intersection of data analytics, content marketing, and community engagement. I have a background in both the Humanities and Data Science with Master's degrees in Philosophy and Social Data Science. That combination lets me bring a combination of rigorous analytical thinking and curiosity to every project. To me, any good form data-driven work means staying focused on why the data matters and who needs to hear it.

I've been a lead contributor to South Africa's largest tech careers report and dataset, as well as the country's largest community salary benchmarking dataset for tech professionals. My seasonal spend report series for Yoco examined domestic and international tourism behaviour during South Africa's peak travel seasons. This series earned national media syndication and a direct invitation to present findings to the Mayor of Cape Town.

Today, I work across FinTech, InsurTech, tech recruitment, and the nonprofit sector, with clients including Yoco, Feather Insurance, OfferZen, and the People's Water Anti-Corruption Forum. Across my clients my approach remains to find the story hiding in the numbers, and tell it in a way that helps people make better decisions.

I speak on topics related to data-driven storytelling and its applications for businesses, community research, and ways of translating data or statistical insights for non-technical audiences.

I'm Josh Nel and I'm a Johannesburg-based freelance data analyst, storyteller, and community strategist working at the intersection of data analytics, content marketing, and community engagement. I have a background in both the Humanities and Data Sc... Show more

Born in Kindu on September 9, 1999, Gilbert Bemwiz discovered computing at the age of 14 through mobile video games. What started as curiosity slowly became a strong interest in technology, experimentation, and digital systems. Although he had good abilities in mathematics, he chose to study Commercial Informatics because of his passion for computers.

As a teenager, he spent a lot of time experimenting with phones, software, and digital tools, sometimes even damaging devices while trying to understand how they worked. After graduating in 2017, he joined the first cohort of MAPON University in Computer Engineering. Feeling that classroom learning alone was not enough, he spent many hours learning independently in the computer lab, exploring programming, networks, artificial intelligence, and system design.

In 2019, he co-created “Busoga,” a local social network project built in response to the lack of digital platforms adapted to local realities. In 2021, his “Intelligent Virtual Ophthalmologist” project received an innovation award. While working on this healthcare AI project, he faced a major difficulty: the lack of medical datasets adapted to the Congolese context. This experience pushed him to think more deeply about how intelligent systems could still be developed in environments with limited data and resources. These reflections later contributed to the idea he calls “Tradition Learning.”

In December 2025, during DevFest Lubumbashi, Gilbert presented Tradition Learning publicly. The discussions that followed led to the creation of the Tradition Learning Community (TLC), bringing together developers, mathematicians, programmers, and technology enthusiasts interested in exploring practical approaches to AI in low-resource environments.

Alongside his technical work, Gilbert began publishing articles and reflections on intelligent systems, autonomous agents, and applied AI for constrained environments. His interests gradually expanded beyond artificial intelligence alone toward broader questions involving infrastructure, digital accessibility, operational systems, and technological inclusion.

During travels across the Katanga region, including Kolwezi, Likasi, and Kasumbalesa, he became increasingly aware that many African challenges go beyond AI itself. For him, one of the main issues is technological isolation: access to infrastructure, connectivity, stable systems, and operational environments capable of supporting innovation. This experience strengthened his interest in enterprise infrastructure, monitoring systems, and industrial environments.

In 2026, he joined SOMAF Group SARL in Lubumbashi, where he became involved in technical and operational environments linked to critical infrastructure and industrial systems. At the same time, through his experience at Neotex.ai and other applied projects, he continues exploring practical approaches to intelligent systems adapted to African realities.

Today, Gilbert Bemwiz works at the intersection of artificial intelligence, infrastructure, monitoring systems, and operational challenges, with a growing interest in building technological ecosystems adapted to constrained and evolving environments.

Born in Kindu on September 9, 1999, Gilbert Bemwiz discovered computing at the age of 14 through mobile video games. What started as curiosity slowly became a strong interest in technology, experimentation, and digital systems. Although he had good a... Show more

Shreya Gupta is a AI Solutions Architect at NVIDIA, where she partners with cloud providers and enterprise customers to design resilient, scalable training and inference workloads. With deep experience across the ML lifecycle, Shreya helps organizations optimize infrastructure to balance performance, cost, and reliability — from single-GPU prototyping to hyperscale distributed training.

She holds an M.S. in Symbolic Systems from Stanford University with research spanning deep learning, natural language processing, and real-time neural decoding. Previously, Shreya was a founding ML engineer at Lamini AI, building fine-tuning pipelines for large language models used by industry leaders such as AMD, iFit and Instacart. Her background also includes impactful research at Google Translate and Stanford’s Vision and Learning Lab with Prof. Fei-Fei Li, blending theory with hands-on systems work.

Shreya Gupta is a AI Solutions Architect at NVIDIA, where she partners with cloud providers and enterprise customers to design resilient, scalable training and inference workloads. With deep experience across the ML lifecycle, Shreya helps organizati... Show more

Security researcher with a passion for dissecting software to understand its inner workings as well as an odd habit of optimizing proof-of-concept code for no apparent reason.

Security researcher with a passion for dissecting software to understand its inner workings as well as an odd habit of optimizing proof-of-concept code for no apparent reason. Show more

Bharat K Karumuri is a seasoned Analytics & Data Science Leader with over 13 years of experience driving innovation at the intersection of healthcare, marketing analytics, and artificial intelligence. Currently serving as Senior Scientist in Marketing Applied Sciences at General Motors, he leads end-to-end Media Mix Modeling initiatives to optimize multi-hundred-million-dollar media investments across GM brands.
Bharat's expertise spans machine learning, deep learning, natural language processing, computer vision, and econometric modeling, complemented by strong business acumen developed through leadership roles and his ongoing MBA studies at the prestigious McCombs School of Business at UT Austin. His career demonstrates a unique ability to bridge technical excellence with strategic business impact, having delivered measurable results including a 20% lift in campaign ROI, 50% productivity improvements, and $250K+ in annual savings through innovative AI/ML solutions.
With a rich background spanning Fortune 500 organizations and startup environments, Bharat has served in key roles at Horizon Media, DirecTV, and Blue Cross Blue Shield Association, while also demonstrating entrepreneurial leadership as Head of Data & AI at Blabbing Inc and CEO & Co-Founder of EpiFocus LLC, where he successfully secured seed funding for healthcare innovation.
His technical expertise encompasses advanced analytics platforms, including Python, SQL, TensorFlow, PyTorch, and leading cloud technologies (AWS, GCP, Azure). Bharat holds a Ph.D. in Biomedical Engineering and multiple master's degrees, reflecting his deep technical foundation and interdisciplinary approach to problem-solving.
Based in Prosper, Texas, Bharat excels at translating complex analytics into actionable insights that influence executive strategy, while fostering collaborative, high-performing teams through mentorship and cross-functional alignment. He continues to drive transformation in both established enterprises and emerging startups, positioning organizations as data-driven market leaders in an increasingly AI-powered world.

Bharat K Karumuri is a seasoned Analytics & Data Science Leader with over 13 years of experience driving innovation at the intersection of healthcare, marketing analytics, and artificial intelligence. Currently serving as Senior Scientist in Marketin... Show more

I am a Podcaster and Public Speaker who creates content, workshops and talks for businesses as well as the youth . I am always looking to offer my services, and support the youth through my talents and experience. My topics that I touch on are Personal branding, storytelling and Podcasting (media).

I am a Podcaster and Public Speaker who creates content, workshops and talks for businesses as well as the youth . I am always looking to offer my services, and support the youth through my talents and experience. My topics that I touch on are Perso... Show more

Dr. Michael Piepkorn is an esteemed clinical dermatologist, dermatopathologist, and researcher with over five decades of dedicated service to the medical field. He has held numerous academic positions and conducted groundbreaking research, particularly in melanoma skin cancer and psoriasis. His extensive expertise in dermatopathology, which is the study of skin pathology, has solidified his reputation as one of the foremost leaders in his field.

He currently practices at Dermatopathology Northwest in Seattle, Washington, where he diagnoses diseases by analyzing skin biopsies. His work at this clinic is complemented by his role at the University of Washington, where he is part of the pigmented lesion and melanoma clinic at the Roosevelt outpatient facility. His ability to combine clinical practice with research ensures he remains at the forefront of the fight against skin cancer.

With board certifications in pathology, dermatology, and dermatopathology, Piepkorn's qualifications and experience are extensive. He has held prominent academic roles at the University of Utah and the University of Washington, contributing to advancing medical knowledge and dermatology practices. In 2000, he co-founded a skin pathology lab in Bellevue, Washington, which has become a vital center for diagnosing and treating skin diseases. His work in both clinical and academic settings has been instrumental in pushing the boundaries of dermatopathology.

One of Michael Piepkorn, PHD's most notable contributions to medical science was identifying the p16 or CDKN2A gene linked to familial melanoma. This discovery marked a pivotal moment in melanoma research, providing invaluable insight into the genetic components of skin cancer. Recognizing his research and clinical expertise, the American Society of Dermatopathology awarded Dr. Michael an honor in 2004, further cementing his standing in the field.

He has published more than 170 original journal articles related to medicine. A sample of Dr. Piepkorn’s prolific work includes the following:
“Pathologists' Diagnosis of Invasive Melanoma and Melanocytic Proliferations: Observer Accuracy and Reproducibility Study”
“Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions”
“Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual”
“Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions”
“Characteristics and Diagnostic Performance of Pathologists Who Enjoy Interpreting Melanocytic Lesions”
“Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing”
“Pathologist Characteristics Associated with Accuracy and Reproducibility of Melanocytic Skin Lesion Interpretation”
“Skin Cancer Screening: Recommendations for Data-driven Screening Guidelines and a Review of the U.S. Preventive Services Task Force Controversy”
“Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous”
“Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions”
“Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions.”
“Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement”
“MPATH-Dx Version 2.0 Schema for Melanocytic Lesions: A Robust Tool for Standardized Diagnostic Reporting”
“Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5”

In addition to his clinical and research contributions, Dr. Piepkorn has played an integral role in educating the next generation of dermatologists and dermatopathologists. He has mentored many young physicians, helping to shape their careers and instilling in them a commitment to scientific research and patient care. His mentorship has helped ensure that the next generation of medical professionals continues pushing the boundaries of knowledge in dermatopathology and melanoma research.

He has been a vital educator at the University of Washington, training numerous clinical and dermatopathologists. His dedication to educating future physicians has had a lasting impact on the field, with his students going on to contribute to medical research and practice.

His impressive educational background laid the foundation for his successful career. He received his medical degree from the University of Minnesota in 1973 and earned a PhD from the University of Washington in 1980. His residency in pathology and dermatology was completed at the University of Washington, where he also held a joint faculty appointment in the Department of Dermatology and Pathology during the 1990s. These academic experiences were crucial in shaping his understanding of dermatology's clinical and research aspects.

Piepkorn's undergraduate studies at Gustavus Adolphus College in Minnesota provided the initial academic foundation that allowed him to pursue his medical career with distinction. His educational journey reflects his lifelong commitment to learning and his passion for advancing the medical field.

He has been recognized for his outstanding contributions to dermatology and medical education. He has received multiple teaching awards, including the Clinical Faculty Distinguished Teaching Award from the University of Washington’s Residency Program in 2009 and 2018. These awards highlight his exceptional abilities as both a clinician and a mentor.

The Michael Piepkorn Endowed Chair in Dermatology Research was established at the University of Washington in 2011 to honor his significant contributions to the field.

Piepkorn, MD, enjoys outdoor activities outside of his professional accomplishments. He has a passion for landscaping and gardening, and he frequently spends time in nature, participating in backpacking, mountaineering, and photography. His love for climbing has led him to scale hundreds of mountains in the United States and abroad, reinforcing his deep connection to the natural world.

Dr. Michael Piepkorn is an esteemed clinical dermatologist, dermatopathologist, and researcher with over five decades of dedicated service to the medical field. He has held numerous academic positions and conducted groundbreaking research, particular... Show more

Dr. Michael Piepkorn is a clinical dermatologist and dermatopathologist with more than 50 years of experience, specializing in the diagnosis of complex skin diseases. His expertise focuses on skin pathology, particularly melanoma and psoriasis. He currently evaluates skin biopsies at Dermatopathology Northwest in Seattle and serves patients through a specialized pigmented lesion and melanoma clinic at the University of Washington’s Roosevelt facility.

Over the course of his career, Michael Piepkorn, MD, has earned board certifications in pathology, dermatology, and dermatopathology, reflecting his broad training across related medical fields. He has held teaching and research positions at both the University of Utah and the University of Washington. His scientific impact includes helping identify the essential familial melanoma gene p16/CDKN2A, a discovery that advanced understanding of the biology of hereditary skin cancer.

Michael Piepkorn, PhD, has published more than 170 scientific articles on topics including diagnostic accuracy in melanocytic lesions, second-opinion strategies, staging methods, and changes in melanoma classification terminology. His research has influenced how pathologists approach challenging skin tumors and how to improve consistency in interpretation. In recognition of his contributions, he received a distinguished honor from the American Society of Dermatopathology in 2004 for excellence in melanoma research.

Alongside his scientific achievements, he has guided numerous trainees in dermatology and dermatopathology, supporting their development in both clinical and laboratory settings. His dedication to teaching has brought him multiple awards from the University of Washington, and his influence continues through the Michael Piepkorn Endowed Chair in Dermatology Research. His mentorship has strengthened the next generation of specialists working to advance the study of melanoma and other skin diseases.

Dr. Piepkorn completed his medical degree at the University of Minnesota in 1973 and earned his PhD at the University of Washington in 1980, later holding joint faculty roles in Dermatology and Pathology. He completed residency training at UW and previously studied at Gustavus Adolphus College. Outside his medical work, he enjoys gardening, landscaping, backpacking, mountaineering, and photographing natural landscapes. These interests highlight his appreciation for nature and his commitment to staying active and connected to the outdoors.

Dr. Michael Piepkorn is a clinical dermatologist and dermatopathologist with more than 50 years of experience, specializing in the diagnosis of complex skin diseases. His expertise focuses on skin pathology, particularly melanoma and psoriasis. He cu... Show more

Varun Goguri is a Senior Database Administrator with extensive experience managing enterprise SQL Server and Azure platforms. He is a Microsoft-certified Expert in Data Management and Analytics and holds a Microsoft Fabric Data Engineer Associate certification. With a Master's degree in Software Engineering, Varun brings enterprise-scale Azure SQL architecture expertise to his speaking sessions. He regularly shares his technical insights at varungoguri.com. Beyond data challenges, Varun is an ultra-distance athlete, weight training coach, and certified yoga instructor. Connect with him on LinkedIn at linkedin.com/in/varungoguri.

Varun Goguri is a Senior Database Administrator with extensive experience managing enterprise SQL Server and Azure platforms. He is a Microsoft-certified Expert in Data Management and Analytics and holds a Microsoft Fabric Data Engineer Associate cer... Show more

Richard Pestell earned his M.B., B.S. at the University of Western Australia, graduating at the top of his class, guided by a commitment to medical discovery. His medical training continued as a physician in training at the Royal Perth Hospital and St Vincent's Hospital, Sydney. During these early years, he gained broad experience in Internal Medicine and residency, including oncology, endocrinology, hematology, cardiology, and transplant medicine.

He pursued his interest in cancer biology through advanced research. He completed a Ph.D. at the University of Melbourne's Howard Florey Institute, specializing in oncogene regulation of gene transcription, driven by a mindset focused on disease mechanisms. National scholarships and multiple competitive fellowships, including a Winthrop Fellowship and an NHMRC postgraduate award, supported his academic achievements. These efforts led him to Harvard Medical School and Massachusetts General Hospital, where he trained further as a clinical and research fellow.

Richard continued his academic career at Northwestern University and then at the Albert Einstein College of Medicine. He became a Professor, Chair of the Division of Endocrine-Dependent Tumor Biology, and Co-Director of major cancer research programs. He also held positions at multiple hospitals in New York, helping him remain engaged in patient care and medical education while supporting research programs focused on cancer biology and therapeutics through translational impact.

Richard Pestell’s research contributed to the knowledge base supporting cancer therapeutics. His research on cyclin D1 was cited in the seminal publications underpinning CDK inhibitor clinical trials and their adoption as a standard therapy for breast cancer globally. His work on CCR5 provided the scientific framework for current oncology clinical trials with CCR5 inhibitors. His scholarly record includes over 700 publications, more than 110,000 citations, an h-index of 162, and extensive invitations to give invited lectures around the world.

In 2002, he became the Director of the Lombardi Comprehensive Cancer Center at Georgetown University. He also served as Chair of the Department of Oncology and Associate Vice President at Georgetown University Medical Center. In this capacity, he was responsible for research, clinical operations, and faculty development, and he participated in institutional restructuring and growth. He built community partnerships, enhanced research programs, and expanded clinical services across Georgetown and MedStar systems.

Richard took on additional leadership roles in 2005 as the Director of the Sidney Kimmel Cancer Center, Chair of the Department of Cancer Biology, and head of the Oncology Service Line at Thomas Jefferson University. He later became the Executive Vice President, charged with enterprise-wide strategic decisions across a system of 30,000 employees. At Jefferson, he directed an overall cancer enterprise with an annual budget of> $350 m and led efforts in clinical care, research infrastructure, regional expansion, and team building. During his tenure, the cancer center rose from 64th to 17th.

Richard Pestell held leadership roles in academia outside of the US and contributed to research, education, and outreach initiatives. He was a founding Director of the Delaware Valley Institute for Clinical and Translational Science, helped develop new education pathways for historically black colleges, and led global cancer outreach at the International Network for Cancer Treatment and Research. He also served on faculty or advisory boards with the University of Melbourne, the University of Western Australia, Nanyang Technological University, Xavier University School of Medicine, Kazan Federal University, and several European institutions.

He has served with prominent scientific bodies, including the Academia Europaea, the Hungarian Academy of Sciences, the American Society for Clinical Investigation, and the Royal Society of Biology, among others. His awards included the RD Wright Medallion, the Eric Susman Prize in Medicine, and his appointment as an Officer of the Order of Australia in 2019. He is also the founder of six biotechnology companies: LightSeed, ProstaGene (acquired in 2018), EcoGenome, StromaGenesis, ioROC, and Shenandoah Pharmaceuticals. Along with these ventures, he has raised nearly 50 million dollars from investors, plus more than 80 million dollars as a principal investigator on NIH research grants.

Richard Pestell has remained committed to philanthropy, community service, and cultural engagement. At Georgetown and at Jefferson, he led philanthropic efforts that produced transformational gifts and created new ways to sustain ongoing fundraising in support of cancer care, wellness centers, and community outreach initiatives. He has served on boards including the National Museum of American Jewish History, the Chamber Orchestra of Philadelphia, the Jewish Federation of Greater Philadelphia, the Historic St. Peter’s Church Preservation Corporation, the American Cancer Society committees, and several university societies. He supported the Olivia Newton-John Wellness Center through a fundraising trek on The Great Wall. He now serves as President of the Pennsylvania Cancer and Regenerative Medicine Center, as the Blumberg Distinguished Professor of Translational Medical Research at the Baruch Blumberg Institute, and as a member of the Wistar Institute Cancer Center, continuing to support global cancer programs, mentor scientific leaders, and develop technologies for improved diagnostics and treatment.

“Share hope. Hope sees the invisible, feels the intangible, and achieves the impossible—every day.”

Richard Pestell earned his M.B., B.S. at the University of Western Australia, graduating at the top of his class, guided by a commitment to medical discovery. His medical training continued as a physician in training at the Royal Perth Hospital and S... Show more

Robert Joseph George is a PhD student at Caltech advised by Anima Anandkumar. His research spans AI for mathematics, AI for science, and formal verification, with a focus on theorem prover based infrastructure for trustworthy machine learning and mathematical reasoning. He previously graduated from the University of Alberta with an Honours degree in Applied Mathematics and Computer Science.

Robert Joseph George is a PhD student at Caltech advised by Anima Anandkumar. His research spans AI for mathematics, AI for science, and formal verification, with a focus on theorem prover based infrastructure for trustworthy machine learning and mat... Show more

Armando Herra is a Systems Architect with vast experience in Cloud, Kubernetes, and DevOps Technologies.

Passionate about the Cloud-Native Ecosystem, he's constantly learning and experimenting with new tools and technologies to stay informed about the industry's latest advances and share his knowledge via tech talks.

Armando Herra is a Systems Architect with vast experience in Cloud, Kubernetes, and DevOps Technologies. Passionate about the Cloud-Native Ecosystem, he's constantly learning and experimenting with new tools and technologies to stay informed about... Show more

Satish Mane is a Software Maintenance Engineer at Red Hat, building secure and scalable CI/CD pipelines across hybrid Kubernetes environments. His work focuses on works in Linux package (Python, Ruby, Node.Js, Grub2.) maintenance, cloud infrastructure, and automation GitOps-first delivery models using Tekton, Argo CD, and OpenShift. Passionate about platform engineering and open-source tooling, Satish aims to simplify cloud-native delivery through automation, policy, and real-world best practices

Satish Mane is a Software Maintenance Engineer at Red Hat, building secure and scalable CI/CD pipelines across hybrid Kubernetes environments. His work focuses on works in Linux package (Python, Ruby, Node.Js, Grub2.) maintenance, cloud infrastructu... Show more

Shalyn Nystrom is a Principal Consultant in Data Science & Analytics at Source Allies. She is focused on enabling teams to build products with data in mind, empowering leaders to make data-driven decisions, and elevating clients' AI capabilities from experimentation to operationalized solutions. In addition to her breadth of experience across the data gamut, she is a culture shaper, always looking to help others find their passion and grow.

Shalyn holds a M.S. in Computational Biology from Carnegie Mellon University, and a B.S. in Bioinformatics and Computational Biology from Iowa State University. In her free time, she enjoys family life with her husband and toddler, along with crafting and traveling the world.

Shalyn Nystrom is a Principal Consultant in Data Science & Analytics at Source Allies. She is focused on enabling teams to build products with data in mind, empowering leaders to make data-driven decisions, and elevating clients' AI capabilities from... Show more

Stephanie Lee Hayes is a somatic educator and writer specializing in nervous system education and the biological foundations of emotional safety, learning, and human behavior. Her work focuses on helping people understand how the nervous system shapes attention, perception, and emotional responses, and why physiological safety is the foundation for learning and meaningful change.

She is the founder of Roots & Rituals Somatic Education, where she develops educational guides and resources that translate nervous system science into clear, practical frameworks. Her teaching helps individuals recognize protective nervous system patterns and understand how safety supports engagement, clarity, and connection.

Her work is informed by both scientific research and her own lived and embodied experience navigating nervous system dysregulation, which deepens her ability to translate complex concepts into practical, accessible education.

Stephanie Lee Hayes is a somatic educator and writer specializing in nervous system education and the biological foundations of emotional safety, learning, and human behavior. Her work focuses on helping people understand how the nervous system shape... Show more

Rambabu Mandalapu is an accomplished Physical Design Engineer with over 15 years of experience in advanced SoC and IP-level physical implementation. He has executed multi-million gate designs across technology nodes ranging from 45nm down to 3nm, incorporating ARM cores, DSPs, and complex low-power architectures. He brings deep expertise across the full RTL-to-GDSII flow, including synthesis, floorplanning, placement, clock tree synthesis, routing, timing closure, signoff, and tapeout.
Currently serving as a Physical Design Domain Lead at a leading semiconductor company in Cupertino, California, Rambabu leads physical design efforts for multiple Power Management Unit (PMU) chips at both block and top levels. He is responsible for physical signoff and tapeout to TSMC, ensuring manufacturability and quality, and acts as the primary physical design contact for TSMC, coordinating tapeout milestones and technical readiness. His role involves close collaboration with analog design, system integration, RTL, and packaging teams to resolve integration and constraint challenges while driving timing, power, and physical verification convergence across complex low-power domains.
Previously, Rambabu served as Engineering Manager, Physical Design at Calsoft Labs, where he managed top-level and block-level PnR efforts for advanced-node test chips and delivered high-performance partitions and subsystems for clients including Qualcomm and Samsung. He also contributed to multiple partitions at Microsoft by supporting PnR closure and sign-off. Earlier, at UST Global, he led hard macro implementation and full-chip place and route for networking SoCs at Microsemi. At Qualcomm India, he served as a subsystem physical design lead for modem blocks in MSM chipsets, executing complete physical design cycles across multiple technology nodes.
Rambabu began his career in physical design at CMC India and completed an internship at Intel, where he contributed to the Ivy Bridge processor during his M.Tech program. He holds an M.Tech in VLSI System Design from the National Institute of Technology (NIT), Warangal, and a B.Tech in Electronics & Communication Engineering from Acharya Nagarjuna University.
With extensive experience across advanced process nodes and a consistent record of delivering production-ready silicon, Rambabu brings strong technical expertise, cross-functional collaboration, and execution excellence to complex semiconductor programs.

Rambabu Mandalapu is an accomplished Physical Design Engineer with over 15 years of experience in advanced SoC and IP-level physical implementation. He has executed multi-million gate designs across technology nodes ranging from 45nm down to 3nm, inc... Show more

I am Rajesh Mannam and I am a BioPharma Data Scientist specializing in biologics and
small-molecule analytics across release testing, stability, quality, and commercial
performance.

I am Rajesh Mannam and I am a BioPharma Data Scientist specializing in biologics and small-molecule analytics across release testing, stability, quality, and commercial performance. Show more

I am a researcher and entrepreneur with a focus on memory systems, cultural evolution and rhetoric.

I am a researcher and entrepreneur with a focus on memory systems, cultural evolution and rhetoric. Show more

Sinchan Banerjee is currently a Director of Enterprise Architecture at UST who architects and drives delivery of enterprise-grade data platforms, large-scale data migrations, and digital transformations for the US healthcare industry. With over 15 years of hands-on experience, he has architected, implemented, and delivered data engineering solutions for both batch and streaming workloads with terabytes of data in cloud and on-premises environments.He develops data strategy of next generation products, leads research on how Generative AI can augment data engineering and drives delivery of enterprise-grade data platforms, large-scale data migrations, and digital transformations for the US healthcare industry.His research interests include Agentic AI, data engineering automation, and intelligent data applications.

An expert in scalable data architectures, AWS and Azure stack, service-oriented architectures, and various big data and streaming tools. For his decade long expertise in building data engineering solution, Packt invited him to author their flagship book on data engineering - “Scalable Data Architecture with Java”. He is also lead author of a patent on Predictive analytics and has published several research papers.

Sinchan Banerjee is currently a Director of Enterprise Architecture at UST who architects and drives delivery of enterprise-grade data platforms, large-scale data migrations, and digital transformations for the US healthcare industry. With over 15 y... Show more

Vadim discovered his passion for business analysis at the intersection of his training as psychologist and his deep interest in information technology. With years of business and IT experience in his backpack, he now focusses on training & coaching best practices to the analysts at Colruyt Group IT, and on building a thriving BA community where knowledge sharing is second nature.

Vadim discovered his passion for business analysis at the intersection of his training as psychologist and his deep interest in information technology. With years of business and IT experience in his backpack, he now focusses on training & coaching b... Show more